Adjuvant hydroxyprogesterone caproate in stage I endometrial carcinoma: changes in numbers and reactivities of some blood lymphocyte subpopulations.
D000077713:17 alpha-Hydroxyprogesterone Caproate; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects*; D008875:Middle Aged; D009367:Neoplasm Staging; D045167:Progesterone Congeners / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000276:immunology
D006908:Hydroxyprogesterones; D045167:Progesterone Congeners; D000077713:17 alpha-Hydroxyprogesterone Caproate